Genetic Therapy deal

GTII and Sandoz Pharma Ltd. agreed to develop and market gene therapy-based cancer products using GTII's HS-tk technology, which uses vectors for the transfer of

Read the full 252 word article

How to gain access

Continue reading with a
two-week free trial.